Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. United Kingdom
  4. London Stock Exchange
  5. Arix Bioscience plc
  6. News
  7. Summary
    ARIX   GB00BD045071

ARIX BIOSCIENCE PLC

(ARIX)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news

Total Voting Rights

08/02/2021 | 02:01am EDT
Arix Bioscience PLC (ARIX) 
Total Voting Rights 
02-Aug-2021 / 07:00 GMT/BST 
Dissemination of a Regulatory Announcement, transmitted by EQS Group. 
The issuer is solely responsible for the content of this announcement. 
=---------------------------------------------------------------------------------------------------------------------- 
 
Arix Bioscience plc 
 
Total Voting Rights 
In conformity with 5.6.1R of the Disclosure Guidance and Transparency Rules, Arix Bioscience plc announces that its 
total issued share capital at the close of business on 31 July 2021 comprised 135,609,653 Ordinary Shares of 0.001 
pence each fully paid. This figure includes 4,728,853 Ordinary Shares which are held in Treasury, leaving a balance of 
130,880,800 Ordinary Shares with voting rights. 
The above figure of 130,880,800 may be used by shareholders for the calculations by which they will determine if they 
are required to notify their major interest in, or a change to their major interest in, Arix Bioscience plc under the 
Disclosure Guidance and Transparency Rules. 
 
[ENDS] 
 
For further information, please contact: 
 
Arix Bioscience plc 
Charlotte Parry, Head of Investor Relations 
+44 (0)20 7290 1072 
charlotte@arixbioscience.com 
 
 
 
=---------------------------------------------------------------------------------------------------------------------- 
ISIN:           GB00BD045071 
Category Code:  TVR 
TIDM:           ARIX 
LEI Code:       213800OVT3AHQCXNIX43 
OAM Categories: 2.5. Total number of voting rights and capital 
Sequence No.:   118936 
EQS News ID:    1223171 
 
End of Announcement  EQS News Service 
=------------------------------------------------------------------------------------
 
Image link: 
https://eqs-cockpit.com/cgi-bin/fncls.ssp?fn=show_t_gif&application_id=1223171&application_name=news 
 

(END) Dow Jones Newswires

August 02, 2021 02:00 ET (06:00 GMT)

All news about ARIX BIOSCIENCE PLC
09/20PRESS RELEASE : Rentschler Biopharma appoints Dr. Christian Schetter as Chief Scientific O..
DJ
09/20ARIX BIOSCIENCE PLC(LSE : ARIX) added to S&P Global BMI Index
CI
09/03VC DAILY : Question: What Is Driving Startup -2-
DJ
09/02ARIX BIOSCIENCE : To Invest $11 Million In Disc Medicine
MT
09/02Arix Bioscience participates in USD90 million Series B financing for Disc Medicine
DJ
09/02Disc Medicine, Inc. announced that it has received $90 million in funding from a group ..
CI
09/01Total Voting Rights
DJ
08/31Transaction in own shares
DJ
08/16Transaction in own shares
DJ
08/16Director/PDMR Shareholding
DJ
More news
Financials
Sales 2021 0,50 M 0,69 M 0,69 M
Net income 2021 37,7 M 51,7 M 51,7 M
Net cash 2021 146 M 200 M 200 M
P/E ratio 2021 5,47x
Yield 2021 -
Capitalization 197 M 270 M 270 M
EV / Sales 2021 103x
EV / Sales 2022 83,3x
Nbr of Employees 12
Free-Float 72,2%
Chart ARIX BIOSCIENCE PLC
Duration : Period :
Arix Bioscience plc Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends ARIX BIOSCIENCE PLC
Short TermMid-TermLong Term
TrendsBearishBearishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 3
Last Close Price 1,58 GBX
Average target price 221,50 GBX
Spread / Average Target 13 919%
EPS Revisions
Managers and Directors
Robert William Henry Lyne CEO, COO, Secretary, Director & General Counsel
Marcus Karia Group Finance Director
Peregrine D. E. M. Moncreiffe Non-Executive Chairman
Graeme Smith Chief Technology Officer
Giles Francis Bertram Kerr Non-Executive Director
Sector and Competitors
1st jan.Capi. (M$)
ARIX BIOSCIENCE PLC-26.94%273
INVESTOR AB (PUBL)30.18%68 794
CK HUTCHISON HOLDINGS LIMITED-5.91%25 261
HAL TRUST31.44%15 367
AB INDUSTRIVÄRDEN (PUBL)3.21%14 019
LIFCO AB (PUBL)58.11%13 052